No abstract available.
Humans ; Nephrolithiasis

No abstract available.
Nephrolithiasis* ; Uric Acid*

Medullary sponge kidney is a relatively common, congenital lesion of the renal medulla, which was first described by Lenarduzzi in 1939. Many urologists have been interested in its unknown pathogenesis and complications, such as nephrolithiasis and infection. We report 5 cases of medullary sponge kidney, diagnosed by excretory urography and the literature has been reviewed briefly.
Medullary Sponge Kidney* ; Nephrolithiasis ; Urography

Background. Despite being a clean-contaminated procedure, performed only in patients with sterile urine preoperatively, percutaneous nephrolithotripsy (PCNL) is associated with significant infectious perioperative complications. A local antibiogram is of paramount importance in optimizing antibiotic prophylaxis in PCNL because of the substantial variation in bacterial distribution and antibiotic sensitivity worldwide.

Objectives. The incidence of post-PCNL infectious complications, microorganism distribution, and antibiotic sensitivities from patients admitted for PCNL was determined. The risk factors associated with positive cultures and the development of fever and bacteremia were also analyzed.

Methods. A retrospective study of 102 patients who underwent PCNL under a surveillance protocol was done. The susceptibility of isolates from different specimens was evaluated against the most common antibiotics in the hospital. Chi-square and Student's t-test were used to determine differences in the frequencies and means for other risk factors for those who developed fever and urosepsis and those who did not.

Results. The incidence of fever and urosepsis was 25% and 4%, respectively. The most common organism on urine specimens was Escherichia coli which showed high sensitivity to aminoglycosides. The most common isolate on stones was Pseudomonas aeruginosa, which showed higher sensitivities to the fluoroquinolones. The isolates showed nearly consistent resistance to ceftriaxone. No significant association was found between the clinical variables studied and the occurrence of infectious complications.

Conclusion. There are comparable rates of infectious complications to published literature. A change in antibiotic prophylaxis was warranted, given the high resistance to ceftriaxone and the predominance of Pseudomonas aeruginosa on stone isolates. Further surveillance is required to identify significant risk factors for the development of post-PCNL infectious complications.

Topiramate is an antiepileptic drug widely used to treat various seizures, mood disorders and migraine based on its various pharmacological mechanisms. Even though nephrolithiasis is listed as one of its side effects, there have been no cases reporting nephrolithiasis caused by use of topiramate on Korean pediatric patients. Since the use of topiramate is increasing in many patients, the possibility of nephrolithiasis after the treatment needs to be considered. Here, we report our experience in correcting neprholithiasis by simply discontinuing topiramate without administering any additional treatments.
Anticonvulsants ; Fructose ; Humans ; Migraine Disorders ; Mood Disorders ; Nephrolithiasis ; Seizures

Idiopathic renal hypouricemia is a disorder characterized by impaired urate handling in the renal tubules. This disease usually produces no symptoms, but hematuria, uric acid nephrolithiasis or acute renal failure may develop. A defect in the SLC22A12 gene, which encodes the human urate transporter, is the known major cause of this disorder. We describe a 10-month-old boy with idiopathic renal hypouricemia. He was diagnosed with transient pseudohypoaldosteronism at admission, but hypouricemia was accidentally found through follow-up study. By gene analysis, his diagnosis was confirmed to idiopathic renal hypouricemia. In addition, we report a mutation in the human urate transporter 1 (hURAT1) gene identified in his family.
Acute Kidney Injury ; Diagnosis ; Follow-Up Studies ; Hematuria ; Humans ; Infant ; Male ; Nephrolithiasis ; Pseudohypoaldosteronism ; Uric Acid

PURPOSE: Hypocitraturia is cited as one of the risk factors promoting stone formation or recurrence of nephrolithiasis. We estimated the relationship between hypocitraturia and other metabolic abnormalities, such as hypercalciuria, hyperuricosuria and hyperoxaluria. The effects of potassium citrate medication were also investigated. MATERIALS AND METHODS: We selected 706 renal stone patients with hypocitraturia (<320mg/day), who had received extracorporeal shock wave lithotripsy (ESWL) treatment, and examined the relationship between hypocitraturia and other metabolic abnormalities according to sex and age. We also examined the increment effect of urinary citrate and stone-free rate following potassium citrate (Urocitra(R)) medication. RESULTS: Complicated hypocitraturia (coexistence with other metabolic abnormalities) was found in 332 of the 706 patients (47.0%). Of the 706 patients, 242 (34.3%), 112 (15.9%) and 33 (4.7%) had hyperoxaluria, hyperuricosuria and hypercalciuria, respectively. Complicated hypocitraturia was higher in the male than female subjects, and was statistically significant (50.4% vs. 39.8%). In 287 (77%) of the 373 patients who received potassium citrate treatment, the urinary citrate level was increased. The mean urinary citrate level was significantly increased (142.5 vs. 336.2 mg/day) (p<0.01), but the stone free rate was not following the citrate treatment. CONCLUSIONS: Potassium citrate was effective in increasing the urinary citrate level. However, prophylactic effects of potassium citrate against recurrent nephrolithiasis must be proved by appropriate comparative studies.
Citric Acid ; Female ; Humans ; Hypercalciuria ; Hyperoxaluria ; Lithotripsy ; Male ; Nephrolithiasis* ; Potassium Citrate ; Recurrence ; Risk Factors ; Shock

We present two cases of symptomatic lower pole moiety ureteropelvic junction obstruction (UPJO) in a partially duplicated collecting system that were successfully treated with minimally invasive endourologic procedures. In the first case, we performed retrograde endopyelotomy with the Acucise(R) ureteral cutting balloon device, and in the latter case, we performed percutaneous nephrolithotomy and antegrade endopyelotomy because of the presence of multiple renal stones. Subsequent intravenous pyelography confirmed marked resolution of the obstruction, and both patients remained asymptomatic during 1 year of follow-up.
Follow-Up Studies ; Humans ; Nephrolithiasis ; Nephrostomy, Percutaneous ; Surgical Procedures, Minimally Invasive ; Ureter ; Urography

PURPOSE: The target of our work was to study several biochemical parameters in phospho-calcic and bone metabolism in blood and urine and the bone mineral density of women with recurrent calcium nephrolithiasis. MATERIALS AND METHODS: We conducted a cross-sectional study with a control group of 85 women divided into 3 groups: group 1 consisted of 25 women without a history of nephrolithiasis, group 2 consisted of 35 women with only one episode of calcium nephrolithiasis, and group 3 consisted of 25 women with a history of recurrent calcium nephrolithiasis. Blood and urine biochemical study was performed, including markers related to lithiasis, and a bone mineral density study was done by use of bone densitometry. RESULTS: Patients in group 3 showed statistically significantly elevated calciuria (15.4 mg/dL), fasting calcium/creatinine ratio (0.14), and 24-hour calcium/creatinine ratio (0.21) compared with groups 1 and 2. Moreover, this group of women with recurrent calcium nephrolithiasis had significantly elevated values of beta-crosslaps, a bone resorption marker, compared with groups 1 and 2 (p=0.000) and showed more bone mineral density loss than did these groups. CONCLUSIONS: Recurrent calcium nephrolithiasis in women has a significant association with bone mineral density loss and with values of calciuria, both fasting and 24-hour.
Bone Density ; Bone Resorption ; Calcium ; Cross-Sectional Studies ; Fasting ; Female ; Humans ; Lithiasis ; Nephrolithiasis ; Urolithiasis

Hypercalciuria is the most common metabolic abnormality in patients with calcium nephrolithiasis and oral calcium tolerance test (OCTT) has been developed to diagnose various forms of hypercalciuria. 71 patients with calcium nephrolithiasis who had been admitted to the Dept. of Urology, Pusan National University Hospital during the period of 11/2years from Jan. 1984 to Jun. 1985, were studied for urinary calcium excretion by OCTT constituted of rigorous calcium restriction for 3 days, fasting and calcium loading. The following results were obtained. 1. Of the 71 patients, hypercalciuria was found in 43 cases (61%) and hyperuricosuria in 24 cases (33.8%). Hyperuricosuria was found more frequently in patients with hypercalciuria than patients with normocalciuria. 2. Of 43 cases with hypercalciuria, 11 cases (15%) were classified as absorptive type I, 14 cases (2O %) as absorptive type II 9 cases (13%) as renal hypercalciuria, and 3 cases (4%) as primary hyperparathyroidism. In the other 6 cases, the etiology of the hypercalciuria could not be defined by our simple OCTT. 3. In fasting, urinary Ca/Cr ratio was 0.052+/-0.025 in normocalciuria group, 0.068+/-0.018 in absorptive type I, 0.068+/-0.025 in absorptive type II group, and all these values were in normal limit. In renal hypercalciuria and primary hyperparathyroidism group, the ratios were 0.167+/-0.033 and 0.149+/-0.029, and these values were significantly higher than normal range. 4. After calcium loading, urinary Ca/Cr ratio was 0.105+/-0.041 in normocalciuria group, but in hypercalciuria groups, the ratios were markedly increased to 0.244+/-0.035 in absorptive type I, 0.288+/-0.042 in absorptive type II, 0.263+/-0.068 in renal hypercalciuria, 0.290+/-0.041 in primary hyperparathyroidism group. 5. In renal hypercalciuria, the ratio of renal calcium reabsorption was 97.8+/-O.9%, and tend to be lower than other subgroups of hypercalciuria and normocalciuria group. The ratio of renal phosphorus reabsorption did not show the difference of the values among the subgroups of hypercalciuria and normocalciuria group. OCTT using rigorous calcium restriction for 3 days is recommended as a relatively simple and reliable method of defining the etiology of hypercalciuria.
Busan ; Calcium* ; Diagnosis* ; Fasting ; Humans ; Hypercalciuria* ; Hyperparathyroidism, Primary ; Metabolism ; Nephrolithiasis* ; Phosphorus ; Reference Values ; Urolithiasis ; Urology